The efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis
Authors:
- Katsutoshi AndoKAKatsutoshi Ando
- Masatoshi KuriharaMKMasatoshi Kurihara
- Hideyuki KataokaHKHideyuki Kataoka
- Masako UeyamaMUMasako Ueyama
- Shinsaku TogoSTShinsaku Togo
- Teruhiko SatoTSTeruhiko Sato
- Tokuhide DoiTDTokuhide Doi
- Shin-Ichiro IwakamiSIShin-Ichiro Iwakami
- Kazuhisa TakahashiKTKazuhisa Takahashi
- Kuniaki SeyamaKSKuniaki Seyama
- Masashi MikamiMMMasashi Mikami
- 1 September 2013
- journal article
- Published by Elsevier in Respiratory Investigation
- Vol. 51 (3) , 175-183
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 17 references indexed in Scilit:
- Efficacy and Safety of Sirolimus in LymphangioleiomyomatosisNew England Journal of Medicine, 2011
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- Sirolimus Ameliorated Post Lung Transplant Chylothorax in LymphangioleiomyomatosisThe Annals of Thoracic Surgery, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosisJournal of Human Genetics, 2002
- Mutations in the tuberous sclerosis complex geneTSC2are a cause of sporadic pulmonary lymphangioleiomyomatosisProceedings of the National Academy of Sciences, 2000
- Mutational analysis of the tuberous sclerosis geneTSC2 in patients with pulmonary lymphangioleiomyomatosisJournal of Medical Genetics, 2000
- Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34Science, 1997
- Two loci for Tuberous Sclerosis: one on 9q34 and one on 16p13Annals of Human Genetics, 1994
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993